All In MedTech

Device Trial Radar · NCT06075368

Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of GENOSS SES in Patients With Acute Coronary Syndrome

Last checked: Nov 20, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

757

Actual

Start

Mar 16, 2020

Primary completion

Dec 31, 2025

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Genoss Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the efficacy and safety of the GENOSS SES in patients with acute coronary syndrome (ACS) in real-world pratice.

Conditions

  • Acute Coronary Syndrome
  • Percutaneous Coronary Intervention

Interventions

  • GENOSS Sirolimus Eluting Coronary Stent SystemDevice

    The GENOSS SES is a novel, biodegradable, polymer-coated, sirolimus-eluting stent with a cobalt chromium stent platform and thin strut.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device-oriented composite endpointTime frame: 12 months after the procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.